₹ 105.85

Ind-Swift Laboratories Ltd 

Ind-Swift Laboratories Ltd  is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Ind-Swift Laboratori is ₹ 105.85 that is ₹ 1.95 -1.81% with respect to the previous day’s close price. The stock price of Ind-Swift Laboratori was last updated 17 hours ago.

Ind-Swift Laboratori Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Ind-Swift Laboratori Live Share Price Analysis

₹ 105.85
Open ₹ 108.30
High ₹ 109.55
Marketcap 6.38B
Close ₹ 105.85
Low ₹ 105.35
Volume ₹ 336,146.00

The stock of Ind-Swift Laboratories Ltd  strated the trade at an Open price of ₹ 108.30 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 109.55 and an Intraday Low price of ₹ 105.35%. As per last updated 17 hours ago, the Shares of Ind-Swift Laboratori were trading at a price of ₹ 105.85 which is ₹ 1.95 -1.81% as compared the price ₹ 107.80 at which the stock close on the previous trading day. The total traded volume for the day stood at 336,146 number of shares.

Candlestick Chart of Ind-Swift Laboratori Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Ind-Swift Laboratori Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 105.85₹ 67.05₹ 138.45

Here is Ind-Swift Laboratori’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 138.45. On the lower side, the stock has been to the 52 weeks low price level of ₹ 67.05. It’s last traded price was ₹ 105.85 as on last update 17 hours ago. The one-year line chart clearly shows how the price of Ind-Swift Laboratori’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 71.24 per share (EPS TTM) in the trailing twelve months period. Ind-Swift Laboratori’s last annual dividend rate was %, which translates to a % of annual dividend yield.

Line Chart of Ind-Swift Laboratori Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Ind-Swift Laboratori

Ind-Swift Laboratories Ltd  belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Ind-Swift Laboratori are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Ind-Swift Laboratori

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
₹ 103.35
₹ 2.55

About Ind-Swift Laboratori

Ind-Swift Laboratories Ltd  is a Private Company. The company operates in the Pharmaceuticals & Drugs sector. It is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs). Incorporated in 1995, it has around 26 years of operations. Ind-Swift Laboratori live share price is ₹ 105.85. It is a Small Cap stock and had a market capitalization of ₹ 6,381,379,072.00 as on 17 hours ago.

  • Ind-Swift Labs operates through the bulk drugs and pharmaceuticals segment.
  • The Company has a product portfolio of approximately 50 products across approximately 15 therapeutic segments.
  • It manufactures Clarithromycin powder/granules, Atorvastatin Calcium Crystalline, Roxithromycin and Nitazoxanide.
  • It also manufactures Nateglinide, Dutasteride, Moxifloxacin and Imatinib Mesylate.
  • The Company offers products for various therapeutic categories, such as macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsyhotic, bone resorption inhibitor, hyperparathyrodism, antineoplastic, treatment of premature ejaculation and nootropic.
  • Its research and development projects include Crams for API Development Medicinal Chemistry development for various discovery projects.
  • The Company also operates a menthol and mint products manufacturing facility.

The registered office of Ind-Swift Laboratori is located in Chandigarh, Punjab. The registrar and share transfer agent for Ind-Swift Laboratori is Alankit Assignments Ltd. The Stock Exchanges on which shares of Ind-Swift Laboratories Ltd  is listed includes BSE, NSE, MCX.

Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1496
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and advanced intermediates in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, and antineoplastic, as well as various products for ADHD symptoms. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company also exports its products. The company was incorporated in 1995 and is headquartered in Manimajra, India.
AddressShivalik Enclave, Manimajra, India
Phone91 17 2506 1850

Ind-Swift Laboratori Recent News

No Recent News found for Ind-Swift Laboratories Ltd .